Rankings
▼
Calendar
LFCR FY 2019 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena
LFCR
Lifecore Biomedical, Inc.
$256M
FY 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$558M
+6.4% YoY
Gross Profit
$81M
14.5% margin
Operating Income
-$8M
-1.4% margin
Net Income
$2M
0.4% margin
EPS (Diluted)
$0.07
Cash Flow
Operating Cash Flow
$16M
Free Cash Flow
-$29M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$519M
Total Liabilities
$249M
Stockholders' Equity
$270M
Cash & Equivalents
$1M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$558M
$524M
+6.4%
Gross Profit
$81M
$78M
+3.4%
Operating Income
-$8M
$12M
-167.6%
Net Income
$2M
$25M
-91.5%
← Q4 2018
All Quarters
Q1 2019 →